愛柯迪(600933.SH):擬在2020年度繼續開展遠期結售匯、外匯期權業務
格隆匯3月2日丨愛柯迪(600933.SH)公佈,公司於2020年3月2日召開第二屆董事會第十六次會議審議通過《關於2020年度開展遠期結售匯及外匯期權業務的議案》。根據2019年外匯匯率走勢,為降低匯率波動對公司經營的影響,以積極應對匯率市場的不確定性,公司擬在2020年度繼續開展遠期結售匯、外匯期權業務。在綜合考慮目前公司持有外幣存量情況,並結合2020年預計業務開展收匯情況及結匯資金需求的基礎上,公司及控股子公司累計辦理遠期結售匯、外匯期權業務的餘額不超過等值28億元人民幣(按照合同約定的幣種、匯率計算)。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.